Fig. 1From: Comparison of vascular access outcomes in patients with end-stage renal disease attributed to systemic lupus erythematosus vs. other causes: a retrospective cohort studySelection of study population among U.S. 2010 incident dialysis patients, overall and by systemic lupus erythematosus-attributed and other end-stage renal disease. AVF, arteriovenous fistula; AVG, arteriovenous graft; ESRD, end-stage renal disease; SLE, systemic lupus erythematosusBack to article page